VT
VTRS
Market ClosedViatris Inc.
US
30.00K employees
CEO: Scott Andrew Smith
Founded: 1980
$16.43
+$0.00(+NaN%)
Market Cap
19.13B
Beta
0.90
52W Range
N/A
Dividend Yield
2.92%
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
35.1%
-10.8%
CAGR: -2.6%
Profit after direct costs
Operating Margin
-18.6%
-26467.3%
CAGR: N/A
Core business profitability
Net Margin
-24.6%
454.2%
CAGR: N/A
Bottom line profitability
Revenue Growth
-3.0%
YoY
CAGR: -5.4%
Top line growth rate
Revenue Flow Analysis
Visual flow showing how VTRS allocates revenue across expenses and profit
Fiscal Year 2025
Revenue Distribution
Flow of revenue through cost categories to net income
Gross Margin
35.1%
$5.01B
Operating Margin
-18.6%
$-2.66B
Net Margin
-24.6%
$-3.51B
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.30B | -3.0% | |
| Cost of Revenue | (12.31B) | (9.77B) | (8.99B) | (9.12B) | (9.29B) | 1.9% | |
Gross Profit | 5.58B | 6.50B | 6.44B | 5.62B | 5.01B | -10.8% | |
| Operating Expenses | |||||||
| Research & Development | (681.00M) | (662.20M) | (805.20M) | (808.70M) | (965.90M) | 19.4% | |
| Selling, General & Administrative | (4.53B) | (4.18B) | (4.65B) | (4.43B) | (3.79B) | -14.3% | |
| Depreciation & Amortization | (4.51B) | (3.03B) | (2.74B) | (2.89B) | (2.80B) | -3.3% | |
Operating Income (EBIT) | -34.00M | 1.61B | 766.20M | 10.10M | -2.66B | -26467.3% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (636.20M) | (592.40M) | (573.10M) | (550.00M) | (471.30M) | -14.3% | |
| Other Income/Expenses (Net) | -630.40M | 1.20B | -563.30M | -633.30M | -1.00B | 58.2% | |
Income Before Tax | -664.40M | 2.81B | 202.90M | -623.20M | -3.67B | 488.1% | |
| Income Tax Expense | (604.70M) | (734.60M) | (148.20M) | (11.00M) | (150.10M) | -1464.5% | |
Net Income | -1.27B | 2.08B | 54.70M | -634.20M | -3.51B | 454.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $2 | $0 | $-1 | $-3 | 466.0% | |
| Weighted Avg Shares Outstanding | 1.21B | 1.21B | 1.20B | 1.19B | 1.17B | -1.9% | |
| Weighted Avg Shares Outstanding (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B | -1.9% | |
EBITDA | 4.48B | 6.43B | 3.52B | 2.82B | -395.40M | -114.0% |
Explore VTRS
VTRS in the Healthcare
Large Cap